FDA Inspection 1256471 — HCSC Blood Center
The FDA completed an inspection of HCSC Blood Center on December 6, 2024 in Ewing, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 6, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Ewing, NJ (United States)